SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Relish Pharmaceuticals gets nod for scheme of Arrangement

02 Jan 2013 Evaluate

Relish Pharmaceuticals has received an approval for Scheme of arrangement for revival of the company and Amalgamation of Proper Dealcomm with itself. Further, the company also has received approval for re-organization of Share Capital of company. The appointed date for the same is April 1, 2013. The board of directors at their meeting held on January 1, 2013 approved the same.

Relish Pharmaceuticals is a public limited company with a global perspective, manufacturing, exporting and marketing in both domestic and international markets. The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.

Shukra Pharma Share Price

36.06 0.71 (2.01%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×